Tapentadol: Difference between revisions

Content deleted Content added
Tag: Reverted
m Reverted edits by 106.214.117.219 (talk) (HG) (3.4.10)
Line 78:
 
==Medical use==
[https://sleepingtabs.com/product/tramadol-50-mg/ Tapentadol] is used for the treatment of moderate to severe pain for both acute (following injury, surgery, etc.) and chronic [[musculoskeletal pain]]. It is also specifically indicated for controlling the pain of [[diabetic neuropathy]] when around-the-clock opioid medication is required. Extended-release formulations of tapentadol are not indicated for use in the management of acute pain.<ref name=Fidman2010rev>{{cite journal|title=Role of Tapentadol Immediate Release (Nucynta) in the Management Of Moderate-to-Severe Pain|pmc=2888545|year=2010|last1=Fidman|first1=B|last2=Nogid|first2=A|volume=35|issue=6|pages=330–357|journal=Pharmacy and Therapeutics}}</ref><ref>{{cite web|url=http://reference.medscape.com/drug/nucynta-tapentadol-999202|title=Medscape-Nucynta}}</ref><ref name=Label2013 />
 
Tapentadol is Pregnancy Category C. There are no adequate and well-controlled studies of tapentadol in pregnant women, and tapentadol is not recommended for use in women during and immediately prior to labor and delivery.<ref name=Label2013>[http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022304s014s015lbl.pdf Nucynta Label], last updated October 2013. Main FDA index page is here [http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=submit&searchTerm=Tapentadol] to check for updates.</ref>